Amgen Inc. (AMGN): Price and Financial Metrics

Amgen Inc. (AMGN): $263.38

2.19 (+0.84%)

POWR Rating

Component Grades

Momentum

D

Stability

C

Sentiment

Quality

B

Add AMGN to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#13 of 334

in industry

AMGN Price/Volume Stats

Current price $263.38 52-week high $346.85
Prev. close $261.19 52-week low $253.30
Day low $262.21 Volume 13,687,900
Day high $269.61 Avg. volume 2,693,733
50-day MA $297.17 Dividend yield 3.45%
200-day MA $305.01 Market Cap 141.58B

AMGN Stock Price Chart Interactive Chart >


Amgen Inc. (AMGN) Company Bio


Amgen Inc. (formerly Applied Molecular Genetics Inc.) is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. One of the world's largest independent biotechnology companies, Amgen was established in Thousand Oaks, California, in 1980. Amgen's Thousand Oaks staff in 2017 numbered 5,125 (7.5% of total city employment) and included hundreds of scientists, making Amgen the largest employer in Ventura County. Focused on molecular biology and biochemistry, its goal is to provide a healthcare business based on recombinant DNA technology. (Source:Wikipedia)  


AMGN Latest News Stream


Event/Time News Detail
Loading, please wait...

AMGN Latest Social Stream


Loading social stream, please wait...

View Full AMGN Social Stream

AMGN Price Returns

1-mo -10.58%
3-mo -19.77%
6-mo -14.54%
1-year -4.51%
3-year N/A
5-year 26.61%
YTD -5.79%
2023 13.46%
2022 20.43%
2021 0.87%
2020 -1.99%
2019 27.60%

AMGN Dividends

Ex-Dividend Date Type Payout Amount Change
Loading, please wait...
View Full AMGN Dividend History

Continue Researching AMGN

Want to see what other sources are saying about Amgen Inc's financials and stock price? Try the links below:

Amgen Inc (AMGN) Stock Price | Nasdaq
Amgen Inc (AMGN) Stock Quote, History and News - Yahoo Finance
Amgen Inc (AMGN) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!